Our President and CEO, Diana Caldwell will once again be attending the 2014 Diversity Alliance for Science Conference May 19-21, 2014. They event is sold out, but to learn more about DA4S, click here. Let us know if you’ll be at the conference or in the area. To...
Our office will be closed December 24th, 25th, 31st and also on January 1st for the holidays. There will be an IRB Board meeting December 23rd . The week of January 6th, the normal IRB Board meeting schedule will resume. If you need to talk to us about your need for...
Check out this article (login registration is required) entitled “What could proposed changes to the Common Rule mean to sites, sponsors and IRBs” published in the Q2 2013 edition of the Society for Clinical Research Sites’ online journal, InSite. ...
We are looking for a new talent to join the Pearl team. Effective immediately, Pearl Pathways in Indianapolis, Indiana has a new position open for a Regulatory Publication Coordinator. Please see the job description online here. Experience with eCTD for an NDA or...
The final FDA guidance entitled “Guidance for Industry Oversight of Clinical Investigations —A Risk-Based Approach to Monitoring,” issued early August is similar to the draft guidance published in 2011. FDA encourages risk based remote monitoring,...
